Clinical Trial Update: Tofacitinib Combined With Chidamide in R/R ENKTCL [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the combination of tofacitinib with chidamide in relapsed/refractory Extranodal NK/T-cell lymphoma; current status is unk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma

Drugs mentioned

• Chidamide (chidamide)
• Tofacitinib (tofacitinib)

Snippet

Sponsor: Sichuan University | Conditions: Extranodal NK/T-cell Lymphoma | Phase 2 | Status: UNKNOWN